AKTX - Akari Therapeutics Plc
1.2601
-0.080 -6.341%
Share volume: 17,524
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$1.34
-0.08
-0.06%
Summary score
44%
Profitability
35%
Dept financing
33%
Liquidity
25%
Performance
60%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2020 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-150.73%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
248.66%
Debt ratio change over timeo
0%
Current Ratio
0.44%
Quick Ratio
0%
Cash Position Ratio
0.31%
Short-term ratios 30-Sep-2023 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-150.73%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
248.66%
Debt ratio change over timeo
0%
Current Ratio
0.44%
Quick Ratio
0%
Cash Position Ratio
0.31%
Last quarter ratios 30-Sep-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-103.47%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
344.84%
Debt ratio change over time
0%
Current Ratio
0.29%
Quick Ratio
0%
Cash Position Ratio
0.24%
Performance ratios (change over 4 years) 30-Sep-2020 - 30-Sep-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AKTX | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 16.88% | 8.66% | 0% |
| Return on assets | -150.73% | 4.12% | 3.03% | 0% |
| Return on sales | 0% | 27.18% | 25.3% | 0% |
| Return on invested capital | 0% | 8.66% | 8.57% | 0% |
| Profitability | 0% | 100% | 79% | 0% |
| Total debt ratio | 248.66% | 81.83% | 59.94% | 0% |
| Debt ratio change over time | 0% | -9.8% | -44.51% | 0% |
| Dept financing | 50% | 8% | 6% | 0% |
| Current Ratio | 0.44% | 1.17% | 1.11% | 0% |
| Quick Ratio | 0% | 0.9% | 0.87% | 0% |
| Cash Position Ratio | 0.31% | 0.12% | 0.46% | 0% |
| Liquididy | 23% | 56% | 75% | 0% |
| Short-term ratios | AKTX | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -150.73% | 3.72% | 2.43% | 0% |
| Return on sales | 0% | 25.09% | 24.4% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 41% | 0% |
| Total debt ratio | 248.66% | 81.36% | 59.85% | 0% |
| Debt ratio change over time | 0% | -188.07% | 0.54% | 0% |
| Dept financing | 25% | 8% | 31% | 0% |
| Current Ratio | 0.44% | 1.17% | 1.11% | 0% |
| Quick Ratio | 0% | 0.9% | 0.87% | 0% |
| Cash Position Ratio | 0.31% | 0.12% | 0.46% | 0% |
| Liquididy | 26% | 57% | 73% | 0% |
